198 related articles for article (PubMed ID: 37260987)
1. Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics.
Yang Y; Pang Q; Hua M; Huangfu Z; Yan R; Liu W; Zhang W; Shi X; Xu Y; Shi J
Front Oncol; 2023; 13():1170567. PubMed ID: 37260987
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma.
Zhang W; Liu W; Yang Y; Xiao C; Xiao Y; Tan X; Pang Q; Wu H; Hua M; Shi X
Front Oncol; 2023; 13():1102623. PubMed ID: 37035174
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
[TBL] [Abstract][Full Text] [Related]
4. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
5. Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinoma.
Daza J; Salomé B; Okhawere K; Bane O; Meilika KN; Korn TG; Qi J; Xe H; Patel M; Brody R; Kim-Schulze S; Sfakianos JP; Lewis S; Rich JM; Zuluaga L; Badani KK; Horowitz A
BJU Int; 2023 Jul; 132(1):75-83. PubMed ID: 36797809
[TBL] [Abstract][Full Text] [Related]
6. Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.
Liu C; Zhang X; Hu C; Liang X; Cao X; Wang D
Front Genet; 2022; 13():877656. PubMed ID: 35774505
[No Abstract] [Full Text] [Related]
7. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma.
Ma X; Sun L
J Cancer; 2023; 14(5):793-808. PubMed ID: 37056387
[No Abstract] [Full Text] [Related]
11. Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma.
Cui K; Song H; Zhang H; Sun P
J Appl Genet; 2024 May; ():. PubMed ID: 38780866
[TBL] [Abstract][Full Text] [Related]
12. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Sui Y; Lu K; Fu L
PeerJ; 2021; 9():e11272. PubMed ID: 33976979
[TBL] [Abstract][Full Text] [Related]
13. Discovery and construction of prognostic model for clear cell renal cell carcinoma based on single-cell and bulk transcriptome analysis.
Zhang F; Yu S; Wu P; Liu L; Wei D; Li S
Transl Androl Urol; 2021 Sep; 10(9):3540-3554. PubMed ID: 34733651
[TBL] [Abstract][Full Text] [Related]
14. Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
Zhu Z; He A; Lin L; Xu C; Cai T; Lin J
J Cancer; 2020; 11(22):6591-6600. PubMed ID: 33046980
[TBL] [Abstract][Full Text] [Related]
15.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
16. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
18. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
[TBL] [Abstract][Full Text] [Related]
20. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
